This trial is looking at a new way of giving carboplatin chemotherapy called adaptive therapy. It is comparing this to having standard carboplatin chemotherapy for ovarian cancer. It is for women ...

The MarketWatch News Department was not involved in the creation of this content. -- Investment led by T&J Meyer Family Foundation, joined by Varia Ventures, NW Angel Fund and other non-institutional ...

Future financings to progress patented hyperthermic technology aimed at improving chemotherapy therapeutic efficacy, tolerability and treatment outcomes for advanced bladder and peritoneal cancers The ...

Cells in our immune system are best known for providing security against external invaders such as bacteria and viruses. These immune cells also guard against internal threats, including cancerous ...

After spending decades helping others, Troy "T-bone" Wilson is asking for support as the long time Victoria mentor, volunteer ...

Stage 1 mesothelioma is localized. The cancer is confined to one side of the chest lining or one area of the abdomen and has not spread to lymph nodes or distant organs. At this stage, treatment may ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

A trend toward improved progression-free outcomes with HIPEC was noted, even though the patients in the HIPEC group didn’t exhibit improved survival overall compared with those in the conventional IP ...

Given the current lack of data from Iraq regarding peritoneal carcinomatosis (PC) management using Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC), and the diversity ...

Dani Castillo, MD, sheds light on the evolving landscape of first-line therapy in advanced gastric cancer. At the American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium, ...